Essentia BioSciences

BiotechnologyAngelBeijing, Chinaessentiabiosciences.com

Latest round

Angel

Last raised

Oct 2023

Total raised

Undisclosed

Investors

5

About Essentia BioSciences

, Ltd, trading as Essentia BioSciences is a biotechnology company specializing in the development, manufacture and marketing of human induced pluripotent stem cell-derived cellular drugs and generic iPSC (induced pluripotent stem cells) drugs. The core team consists of people from Cambridge University, Oxford University and Peking University. It was awarded the title of Zhongguancun High-Tech Enterprise in March 2023. The company is engaged in the research, development, manufacture and sale of human induced pluripotent stem cell-derived cell drugs and generic iPSC drugs. It also provides treatment options for serious illnesses such as diabetes, cardiovascular disease, and neurodegenerative diseases. The company generates revenue by developing human induced pluripotent stem cell-derived cellular drugs and generic iPSC (induced pluripotent stem cells) drugs.

Who invested in Essentia BioSciences

5 investors across 2 rounds

See all investors in Essentia BioSciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Oct 24, 2023

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Mar 30, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Essentia BioSciences

Who invested in Essentia BioSciences?

Essentia BioSciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Essentia BioSciences raised?

Essentia BioSciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Essentia BioSciences last raise money?

Essentia BioSciences's most recent round on record is a Angel, in Oct 2023.

What does Essentia BioSciences do?

, Ltd, trading as Essentia BioSciences is a biotechnology company specializing in the development, manufacture and marketing of human induced pluripotent stem cell-derived cellular drugs and generic iPSC (induced pluripotent stem cells) drugs.

Where is Essentia BioSciences headquartered?

Essentia BioSciences is headquartered in Beijing, China.

Which VCs invest in companies like Essentia BioSciences?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Essentia BioSciences's stage. Their profiles are linked below.

Raising like Essentia BioSciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.